Testing TTYP01 tablets for autism in kids and teens
Part of Mental health clinical trials.
This study tests an investigational tablet (TTYP01) to see if it can help adolescents and children with autism spectrum disorder (ASD). The goal is to find out if the drug improves symptoms and is safe for this age group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 and 16 years old.
- You must have a diagnosis of autism spectrum disorder (ASD) confirmed by a doctor using standard criteria.
- Your autism symptoms must be at least moderate in severity.
- You must weigh between 44 pounds (20 kg) and 154 pounds (70 kg).
- You cannot have had a seizure in the last 3 months or have certain other mental health conditions like schizophrenia or bipolar disorder.
- You must be willing to stop certain other treatments for autism and ADHD during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
This trial tests if a medicine called suramin (KZ101) can help with social challenges in boys with autism. It's a 12-week study at one location, and families must be able to visit the site easily.
This study tests a type of talk therapy called cognitive behavioral therapy (CBT) to help reduce anxiety in teenagers with autism and intellectual disability. It may help your child learn new ways to cope with anxiety.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
Hear when a new Autism Spectrum Disorder (ASD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.